ALB and myocardial infarction: Within the German Diabetes Dialysis Study (4D), baseline levels of carbamylated albumin (C-Alb) strongly correlated with 1-year cardiovascular mortality (primarily from sudden cardiac death), as well as with 4-year mortality from chronic heart failure, but not with increased risk of myocardial infarction or stroke [15].